Clinical trial NCT06161181 - References

Metastatic Breast Cancer — Enhancing Therapy Adherence Among Metastatic Breast Cancer Patients

Citation(s)

•   Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al
  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 3;85(5):365-76. doi: 10.1093/jnci/85.5.365.
•   Antonovsky A
  The structure and properties of the sense of coherence scale. Soc Sci Med. 1993 Mar;36(6):725-33. doi: 10.1016/0277-9536(93)90033-z.
•   Beck AT, Steer RA, Brown G
  Beck Depression Inventory-II (BDI-II). APA PsycTests. Epub ahead of print 1996
•   Bohlmann A, Mostafa J, Kumar M
  Machine Learning and Medication Adherence: Scoping Review. JMIRx Med. 2021 Nov 24;2(4):e26993. doi: 10.2196/26993.
•   Cardoso F, Paluch-Shimon S, Senkus E, Curigliano G, Aapro MS, Andre F, Barrios CH, Bergh J, Bhattacharyya GS, Biganzoli L, Boyle F, Cardoso MJ, Carey LA, Cortes J, El Saghir NS, Elzayat M, Eniu A, Fallowfield L, Francis PA, Gelmon K, Gligorov J, Haidinger R, Harbeck N, Hu X, Kaufman B, Kaur R, Kiely BE, Kim SB, Lin NU, Mertz SA, Neciosup S, Offersen BV, Ohno S, Pagani O, Prat A, Penault-Llorca F, Rugo HS, Sledge GW, Thomssen C, Vorobiof DA, Wiseman T, Xu B, Norton L, Costa A, Winer EP
  5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol. 2020 Dec;31(12):1623-1649. doi: 10.1016/j.annonc.2020.09.010. Epub 2020 Sep 23. No abstract available.
•   Cleeland CS, Ryan KM
  Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994 Mar;23(2):129-38.
•   Gennari A, Andre F, Barrios CH, Cortes J, de Azambuja E, DeMichele A, Dent R, Fenlon D, Gligorov J, Hurvitz SA, Im SA, Krug D, Kunz WG, Loi S, Penault-Llorca F, Ricke J, Robson M, Rugo HS, Saura C, Schmid P, Singer CF, Spanic T, Tolaney SM, Turner NC, Curigliano G, Loibl S, Paluch-Shimon S, Harbeck N; ESMO Guidelines Committee
  Electronic address: clinicalguidelines@esmo.org. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer. Ann Oncol. 2021 Dec;32(12):1475-1495. doi: 10.1016/j.annonc.2021.09.019. Epub 2021 Oct 19. No abstract available.
•   Jansen LA, Appelbaum PS, Klein WM, Weinstein ND, Cook W, Fogel JS, Sulmasy DP
  Unrealistic optimism in early-phase oncology trials. IRB. 2011 Jan-Feb;33(1):1-8. No abstract available.
•   Karanasiou GS, Tripoliti EE, Papadopoulos TG, Kalatzis FG, Goletsis Y, Naka KK, Bechlioulis A, Errachid A, Fotiadis DI
  Predicting adherence of patients with HF through machine learning techniques. Healthc Technol Lett. 2016 Sep 27;3(3):165-170. doi: 10.1049/htl.2016.0041. eCollection 2016 Sep.
•   Komatsu H, Yagasaki K, Yamaguchi T, Mori A, Kawano H, Minamoto N, Honma O, Tamura K
  Effects of a nurse-led medication self-management programme in women with oral treatments for metastatic breast cancer: A mixed-method randomised controlled trial. Eur J Oncol Nurs. 2020 Aug;47:101780. doi: 10.1016/j.ejon.2020.101780. Epub 2020 Jun 14.
•   Lin C, Clark R, Tu P, Bosworth HB, Zullig LL
  Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers. Breast Cancer Res Treat. 2017 Sep;165(2):247-260. doi: 10.1007/s10549-017-4317-2. Epub 2017 Jun 1.
•   Marshall VK, Visovsky C, Advani P, Mussallem D, Tofthagen C
  Cancer treatment-specific medication beliefs among metastatic breast cancer patients: a qualitative study. Support Care Cancer. 2022 Aug;30(8):6807-6815. doi: 10.1007/s00520-022-07101-7. Epub 2022 May 9.
•   Merluzzi TV, Nairn RC, Hegde K, Martinez Sanchez MA, Dunn L
  Self-efficacy for coping with cancer: revision of the Cancer Behavior Inventory (version 2.0). Psychooncology. 2001 May-Jun;10(3):206-17. doi: 10.1002/pon.511.
•   Mirzadeh SI, Arefeen A, Ardo J, Fallahzadeh R, Minor B, Lee JA, Hildebrand JA, Cook D, Ghasemzadeh H, Evangelista LS
  Use of machine learning to predict medication adherence in individuals at risk for atherosclerotic cardiovascular disease. Smart Health (Amst). 2022 Dec;26:100328. doi: 10.1016/j.smhl.2022.100328. Epub 2022 Oct 4.
•   Montagna E, Zagami P, Masiero M, Mazzocco K, Pravettoni G, Munzone E
  Assessing Predictors of Tamoxifen Nonadherence in Patients with Early Breast Cancer. Patient Prefer Adherence. 2021 Sep 15;15:2051-2061. doi: 10.2147/PPA.S285768. eCollection 2021.
•   Pedrabissi, L
  , & Santinello, M. (1989). Verifica della validità dello STAI forma Y di Spielberger [Verification of the validity of the STAI, Form Y, by Spielberger]. Giunti Organizzazioni Speciali, 191-192, 11-14.
•   R: A language and environment for statistical computing
  R Foundation for Statistical Computing. URL: https://www. R-project.org
•   Scioscia G, Tondo P, Foschino Barbaro MP, Sabato R, Gallo C, Maci F, Lacedonia D
  Machine learning-based prediction of adherence to continuous positive airway pressure (CPAP) in obstructive sleep apnea (OSA). Inform Health Soc Care. 2022 Jul 3;47(3):274-282. doi: 10.1080/17538157.2021.1990300. Epub 2021 Nov 8.
•   Scott NW, Fayers P, Aaronson NK, et al
  EORTC QLQ-C30 Reference Values Manual. (2nd ed.). EORTC Quality of Life Group., 2008
•   Serpentini S, Del Bianco P, Chirico A, Merluzzi TV, Martino R, Lucidi F, De Salvo GL, Trentin L, Capovilla E
  Self-efficacy for coping: utility of the Cancer behavior inventory (Italian) for use in palliative care. BMC Palliat Care. 2019 Apr 5;18(1):34. doi: 10.1186/s12904-019-0420-y.
•   Sica C, Ghisi M
  The Italian versions of the Beck Anxiety Inventory and the Beck Depression Inventory-II: Psychometric properties and discriminant power. In: M. A. Lange. Leading-edge psychological tests and testing research. Nova Science Publishers, 2007, pp. 27-50.
•   Spielberger CD, Gonzalez-Reigosa F, Martinez-Urrutia A, et al
  The State-Trait Anxiety Inventory. Rev Interam Psicol J Psychol 1971; 5: 3-4
•   Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, Cull A, Aaronson NK
  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996 Oct;14(10):2756-68. doi: 10.1200/JCO.1996.14.10.2756.
•   Ubbiali A, Chiorri C, Hampton P, Donati D
  Italian Big Five Inventory. Psychometric properties of the Italian adaptation of the Big Five Inventory (BFI). Bollettino di Psicologia applicata 2013;59(266):37-48
•   Weinstein, N
  D. (1980). Unrealistic optimism about future life events. Journal of Personality and Social Psychology, 39(5), 806-820.
•   Yerrapragada G, Siadimas A, Babaeian A, Sharma V, O'Neill TJ
  Machine Learning to Predict Tamoxifen Nonadherence Among US Commercially Insured Patients With Metastatic Breast Cancer. JCO Clin Cancer Inform. 2021 Aug;5:814-825. doi: 10.1200/CCI.20.00102.
•   Zhu X, Peng B, Yi Q, Liu J, Yan J
  Prediction Model of Immunosuppressive Medication Non-adherence for Renal Transplant Patients Based on Machine Learning Technology. Front Med (Lausanne). 2022 Feb 18;9:796424. doi: 10.3389/fmed.2022.796424. eCollection 2022. Erratum In: Front Med (Lausanne). 2022 Aug 09;9:964157.

Enhancing Therapy Adherence Among Metastatic Breast Cancer Patients: the Study Protocol

Details for clinical trial NCT06161181